JPMorgan Chase lowers Anthem stock to ‘neutral’

Equity researches at JPMorgan Chase downgraded payer Anthem’s stock from an “overweight” rating to a “neutral” rating Monday, according to Community Financial News.  

Advertisement

The downgrade means Anthem stock is expected to perform in line with its average return of stock, rather than outperform its average return of stock as projected.

Indianapolis-based Anthem — which has a 52-week low of $115.63 and a 52-week high of $149.50 — opened at $121.09 Monday.  

More articles about payer issues:
Update: Insurers weigh in on civil rights allegations over HIV drug coverage
11.7 million uninsured eligible for Medicaid, tax credits under ACA
Regulators approve double-digit health plan rate hikes for Illinois

Advertisement

Next Up in Uncategorized

  • Sacroiliac joint fusion technology is advancing, and the data shows it’s efficacy across different medtech companies. Five notes: 1. Tenon…

  • Robert Mach was appointed CEO of Schoolcraft Memorial Hospital in Manistique, Mich., effective Aug. 15. Mr. Mach brings a wealth…

  • Nashville, Tenn.-based HCA Healthcare, the largest health system in the country, is seeking finance chiefs at four of its hospitals. …

Advertisement

Comments are closed.